XML 52 R53.htm IDEA: XBRL DOCUMENT v2.4.0.8
Collaboration Revenue - Summarized Amount of Collaboration Recorded in Consolidated Statement of Operations (Detail) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues $ 12,656 $ 6,028 $ 32,257 $ 16,566
Ziopharm Oncology, Inc.
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 4,014 2,766 11,035 7,775
Synthetic Biologics, Inc.
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 204 339 756 2,889
Oragenics, Inc.
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 264 482 1,372 1,469
Fibrocell Science, Inc.
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 1,463 1,710 4,104 3,071
Genopaver, LLC
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 428 383 1,409 664
S & I Ophthalmic, LLC
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 667   2,153  
OvaXon, LLC
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 813   1,561  
Intrexon Energy Partners, LLC
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 2,160   3,995  
Other Collaborations
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 2,643 348 5,872 698
Upfront and Milestone Payments
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 2,490 1,427 6,889 5,315
Upfront and Milestone Payments | Ziopharm Oncology, Inc.
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 644 644 1,932 1,932
Upfront and Milestone Payments | Synthetic Biologics, Inc.
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 163 163 488 2,024
Upfront and Milestone Payments | Oragenics, Inc.
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 261 138 784 412
Upfront and Milestone Payments | Fibrocell Science, Inc.
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 449 327 1,345 643
Upfront and Milestone Payments | Genopaver, LLC
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 68 68 205 136
Upfront and Milestone Payments | S & I Ophthalmic, LLC
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 0   0  
Upfront and Milestone Payments | OvaXon, LLC
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 0   0  
Upfront and Milestone Payments | Intrexon Energy Partners, LLC
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 625   1,250  
Upfront and Milestone Payments | Other Collaborations
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 280 87 885 168
Research and Development Services
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 10,166 4,601 25,368 11,251
Research and Development Services | Ziopharm Oncology, Inc.
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 3,370 2,122 9,103 5,843
Research and Development Services | Synthetic Biologics, Inc.
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 41 176 268 865
Research and Development Services | Oragenics, Inc.
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 3 344 588 1,057
Research and Development Services | Fibrocell Science, Inc.
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 1,014 1,383 2,759 2,428
Research and Development Services | Genopaver, LLC
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 360 315 1,204 528
Research and Development Services | S & I Ophthalmic, LLC
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 667   2,153  
Research and Development Services | OvaXon, LLC
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 813   1,561  
Research and Development Services | Intrexon Energy Partners, LLC
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues 1,535   2,745  
Research and Development Services | Other Collaborations
        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Collaboration revenues $ 2,363 $ 261 $ 4,987 $ 530